TGI
TRV GP IV Portfolio holdings
AUM
$163M
This Quarter Return
+44.29%
1 Year Return
-8.31%
3 Year Return
+262.88%
5 Year Return
+149.36%
10 Year Return
–
AUM
$271M
AUM Growth
+$271M
(-13%)
Cap. Flow
-$117M
Cap. Flow
% of AUM
-43.04%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Relay Therapeutics
RLAY
|
$117M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Dianthus Therapeutics
DNTH
$759M
| $94.8M | 34.93% |
8,008,204
| – | – |
|
2
Pliant Therapeutics
PLRX
$101M
| $83.9M | 30.9% |
2,132,867
| – | – |
|
3
Revolution Medicines
RVMD
$7.1B
| $65.1M | 24% |
1,419,900
| – | – |
|
4
Fulcrum Therapeutics
FULC
$351M
| $27.6M | 10.17% |
2,343,154
| – | – |
|
|
5
Relay Therapeutics
RLAY
$619M
| – | – |
-2,811,197
| Closed | -$117M |
|